Premium
Human pyrroline‐5‐carboxylate reductase (PYCR1) acts on Δ 1 ‐piperideine‐6‐carboxylate generating L‐pipecolic acid
Author(s) -
Struys Eduard A.,
Jansen Erwin E. W.,
Salomons Gajja S.
Publication year - 2014
Publication title -
journal of inherited metabolic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.462
H-Index - 102
eISSN - 1573-2665
pISSN - 0141-8955
DOI - 10.1007/s10545-013-9673-4
Subject(s) - pipecolic acid , proline , carboxylate , chemistry , reductase , lysine , enzyme , amino acid , biochemistry
We have conducted biochemical studies with commercial available pyrroline‐5‐carboxylate (P5C) reductase (PYCR1) to investigate whether this enzyme plays a role in L‐lysine degradation. Our recent studies with antiquitin/ALDH7A1 deficient fibroblasts revealed an alternative genesis of L‐pipecolic acid, and we then hypothesized that PYCR1 was responsible for the conversion of Δ 1 ‐piperideine‐6‐carboxylate (P6C) into pipecolic acid. We here present evidence that PYCR1 is indeed able to produce L‐pipecolic acid from P6C preparations, and the observed K m for this conversion is of the same magnitude as the K m described for the conversion of P5C to L‐proline by PYCR1. Urine samples from antiquitin deficient individuals, who accumulate P6C, were also incubated with PYCR1 which resulted in a marked decrease of P6C and a huge increase of L‐pipecolic acid as measured by LC‐MS/MS, confirming that indeed PYCR1 generates L‐pipecolic acid from P6C.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom